You are here

Ofer Shapira


Wala JA*, Shapira O*, Li Y, et al. Selective and mechanistic sources of recurrent rearrangements across the cancer genome. Submitted for publication.

Hsu CW, Shen Y, Zhen B, et al. Novel phenomena in nano-photonic systems of macroscopic sizes. Proc. SPIE 9162, Active Photonic Materials VI. 91620R (12 September 2014).

Zhen B, Chua S-L, Lee J, et al. Novel phenomena in macroscopic photonic crystals. Proc. SPIE 8808, Active Photonic Materials V. 880814 (11 September 2013).

Ofer Shapira, Ph.D.

Ofer Shapira is a staff scientist in the Cancer Program of the Broad Institute of MIT and Harvard, where he works under the direction of Rameen Beroukhim to identify somatic genetic alterations that occur in cancer and understand the mechanistic and selective processes that contribute to tumor growth. Shapira develops statistical and machine learning models applied to large datasets of whole genome sequences to identify novel oncogenic rearrangements.

Prior to joining the Broad Institute in 2016, Shapira was a co-founder of Nano-Spect, Inc., a startup that developed drug compound screening technology aiming at providing lower-cost and higher throughput structure-based protein-ligand screening. He previously worked as the R&D group leader for QD Vision and as a senior optical engineer for Chromatis Networks.

Shapira obtained a Ph.D. in electrical engineering and computer science at the Massachusetts Institute of Technology, where he also completed his postdoctoral research in nanophotonics, light-matter interaction, and novel fibers. He holds a B.S. and M.S. in electrical engineering from Technion-Machon Technologi Le’Israel.

Contact Ofer Shapira via email at